The Claim

In high-fat diet-fed rats, the combination of dapagliflozin and 16:8 intermittent fasting increases adipose tissue p-AMPK expression by 181.8% and SIRT1 expression by 263.6%, and decreases SIRT7 expression by 59.7%, compared to high-fat diet-fed control rats, indicating enhanced activation of energy-sensing pathways that suppress adipogenesis and promote fat mobilization.

Source: Dapagliflozin-intermittent fasting combination maximizes weight and metabolic regulation through AMPK/sirtuins/clock genes and gut microbiota signaling in high-fat diet-induced obesity: a novel anti-obesity approach

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
19score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In rats fed a high-fat diet, combining the drug dapagliflozin with 16:8 intermittent fasting increases levels of p-AMPK and SIRT1 proteins in fat tissue while decreasing SIRT7 levels, which corresponds to changes in molecular pathways linked to reduced fat storage and increased fat breakdown.

See the scientific wording

In high-fat diet-fed rats, the combination of dapagliflozin and 16:8 intermittent fasting increases adipose tissue p-AMPK and SIRT1 expression by 181.8% and 263.6%, respectively, and decreases SIRT7 expression by 59.7%, compared to high-fat diet controls, suggesting enhanced activation of energy-sensing pathways that suppress adipogenesis and promote fat mobilization.

Why this might work

When the body is deprived of food for long periods and glucose is lost in urine, cells sense low energy and turn on AMPK, which activates SIRT1. SIRT1 then shuts down fat-storing genes and turns on fat-burning and heat-producing pathways. At the same time, a fat-storing signal called SIRT7 is turned off, which removes its block on SIRT1, making the fat-burning process even stronger. This combination stops new fat cells from forming and breaks down existing fat stores.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Dapagliflozin-intermittent fasting combination maximizes weight and metabolic regulation through AMPK/sirtuins/clock genes and gut microbiota signaling in high-fat diet-induced obesity: a novel anti-obesity approach

    In obese rats, combining a diabetes drug with daily 16-hour fasting turned up fat-burning signals (AMPK and SIRT1) and turned down a fat-storing signal (SIRT7), exactly as the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.